Targeting serotonin receptors with phytochemicals – an in-silico study DOI Creative Commons
Amir Elalouf,

Amit Yaniv Rosenfeld,

Hanan Maoz

и другие.

Scientific Reports, Год журнала: 2024, Номер 14(1)

Опубликована: Дек. 5, 2024

The potential of natural phytochemicals in mitigating depression has been supported by substantial evidence. This study evaluated a total 88 with antidepressant properties targeting serotonin (5-HT) receptors (5-HT1A, 5-HT4, and 5-HT7) using molecular docking, ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) analysis, internal coordinates normal mode analysis (NMA), dynamics simulation (MDS), free energy calculation. Five compounds (Genistein, Kaempferol, Daidzein, Peonidin, glycitein) exhibited favorable pharmacokinetic improved binding scores, indicating their as effective antidepressants. Redocking superimposition 5-HT cocrystal structures validated these findings. Furthermore, NMA, MDS, calculations confirmed the stability deformability ligand-receptor complexes, suggesting that can effectively interact to modulate depressive symptoms. These powerful phytochemicals, abundantly found soybeans, fruits, vegetables, herbs, represent promising avenue for developing treatments depression. Further vitro vivo studies are warranted explore efficacy alleviating stress through interactions receptors.

Язык: Английский

Agarwood as a neuroprotective agent: a comprehensive review of existing evidence and potential avenues for future research DOI
Ankur Das, Khaleda Begum, Raja Ahmed

и другие.

Phytochemistry Reviews, Год журнала: 2025, Номер unknown

Опубликована: Апрель 7, 2025

Язык: Английский

Процитировано

0

Elucidating the Antidepressant-Like Effect of Tannic Acid in Mice: Modulation of Serotonergic System and Pro-Inflammatory Mediators DOI
Karina Pereira Luduvico, Júlia Eisenhardt de Mello, Solange Vega Custódio

и другие.

Molecular Neurobiology, Год журнала: 2025, Номер unknown

Опубликована: Май 27, 2025

Язык: Английский

Процитировано

0

Converging circuits between pain and depression: the ventral tegmental area as a therapeutic hub DOI Creative Commons
Montse Flores-García, Arianna Rizzo,

Maria Zelai Garçon-Poca

и другие.

Frontiers in Pharmacology, Год журнала: 2023, Номер 14

Опубликована: Окт. 2, 2023

Chronic pain and depression are highly prevalent pathologies cause a major socioeconomic burden to society. affects the emotional state of individuals suffering from it, while worsens prognosis chronic patients may diminish effectiveness treatments. There is high comorbidity rate between both pathologies, which might share overlapping mechanisms. This review explores evidence pinpointing role for ventral tegmental area (VTA) as hub where processing converge. In addition, feasibility using VTA possible therapeutic target discussed. The VTA, dopaminergic system in general, studied mood disorders, especially deficits reward-processing motivation. Conversely, less regarded it concerns study central mechanisms its mood-associated consequences. Here, we first outline brain circuits involving focusing on often-understudied VTA. Next, highlight state-of-the-art findings supporting emergence link pathways Thus, envision promising part putative innovative approaches treat effects mood. Finally, emphasize urge develop use animal models depression-like symptoms considered conjunction.

Язык: Английский

Процитировано

7

Atractylenolide I improves behaviors in mice with depression‐like phenotype by modulating neurotransmitter balance via 5‐HT2A DOI
Hongyan Pei, Rui Du, Zhongmei He

и другие.

Phytotherapy Research, Год журнала: 2023, Номер 38(1), С. 231 - 240

Опубликована: Окт. 19, 2023

Abstract To explore the antidepressant effects and targets of atractylenolide I (ATR) through a network pharmacological approach. Relevant ATR depression analyzed by pharmacology were scored (identifying 5‐HT2A targets). Through elevated plus maze, open field, tail suspension, forced swimming tests, behavioral changes mice with (chronic unpredictable mild stress [CUMS]) examined, levels neurotransmitters including serotonin, dopamine, norepinephrine (5‐HT, DA, NE) determined. The binding to was verified small molecular‐protein docking. improved behaviors CUMS mice, their 5‐HT, NE, exerted protective effect on nerve cell injury. After knockout, failed further improve behaviors. According results docking analysis, acted as an inhibitor 5‐HT2A. can modulate targeting

Язык: Английский

Процитировано

7

SmartStim: An Artificial Intelligence Enabled Deep Brain Stimulation Device DOI
Dean M. Corva, Brenna Parke,

Alyssa M. West

и другие.

IEEE Transactions on Medical Robotics and Bionics, Год журнала: 2024, Номер 6(2), С. 674 - 684

Опубликована: Март 25, 2024

Deep brain stimulation (DBS) has demonstrated therapeutic efficacy in the treatment of neurological and psychiatric disorders. Currently, DBS devices employ an openloop configuration, requiring manual adjustment electrical to address patient needs. For this reason, closed-loop is being developed, delivering appropriate ondemand based on internal signal monitoring. A key challenge current research complexity interpreting measured signals interventions, currently no miniaturised device on-board artificial intelligence (AI) meet need. This paper presents a new device, named SmartStim, that uses AI monitor dynamically changing biomarkers. In addition, decides if output stimulator required for treatment. two components: hardware module (neural sensor unit, processor, neurostimulator) software (data processing, AI, firmware). The neural unit comprised subcomponents. first potentiostat can perform impedance analysis, second dedicated fast scan cyclic voltammetry (FSCV) front-end rates up 1000 V/s. currentcontrolled waveforms frequency range 5 Hz–200 Hz, 1 μA 10 mA, with active charge balancing. Five experiments were conducted validate SmartStim: static resistive load test, emulated resistance electrochemical cell dynamic serotonin test. These confirm potential SmartStim identify neurochemical patterns mouse using AI.

Язык: Английский

Процитировано

2

Advances in drug design and therapeutic potential of selective or multitarget 5‐HT1A receptor ligands DOI
Gianfabio Giorgioni, Alessandro Bonifazi, Luca Botticelli

и другие.

Medicinal Research Reviews, Год журнала: 2024, Номер 44(6), С. 2640 - 2706

Опубликована: Май 29, 2024

5-HT1A receptor (5-HT1A-R) is a serotoninergic G-protein coupled subtype which contributes to several physiological processes in both central nervous system and periphery. Despite being the first 5-HT-R identified, cloned studied, it still represents very attractive target drug discovery continues be focus of myriad campaigns due its involvement numerous neuropsychiatric disorders. The structure-activity relationship studies (SAR) performed over last years have been devoted three main goals: (i) design synthesis 5-HT1A-R selective/preferential ligands; (ii) identification biased agonists, differentiating pre- versus post-synaptic agonism signaling cellular mechanisms; (iii) development multitarget compounds endowed with well-defined poly-pharmacological profiles targeting along other serotonin receptors, transporter (SERT), D2-like receptors and/or enzymes, such as acetylcholinesterase phosphodiesterase, promising strategy for management complex psychiatric neurodegenerative In this review, medicinal chemistry aspects ligands acting or agonists antagonists belonging different chemotypes developed 7 (2017-2023) discussed. chemical pharmacological tools molecular imaging also described. Finally, interest therapeutic potential considered.

Язык: Английский

Процитировано

2

Design and Synthesis of Potential Multi-Target Antidepressants: Exploration of 1-(4-(7-Azaindole)-3,6-dihydropyridin-1-yl)alkyl-3-(1H-indol-3-yl)pyrrolidine-2,5-dione Derivatives with Affinity for the Serotonin Transporter DOI Open Access
Martyna Z. Wróbel,

Andrzej Chodkowski,

Agata Siwek

и другие.

International Journal of Molecular Sciences, Год журнала: 2024, Номер 25(20), С. 11276 - 11276

Опубликована: Окт. 20, 2024

We describe the design, synthesis and structure–activity relationship of a novel series 1-(4-(7-azaindole)-3,6-dihydropyridin-1-yl)alkyl-3-(1H-indol-3-yl)pyrrolidine-2,5-dione derivatives with combined effects on serotonin (5-HT1A) dopamine (D2) receptors (5-HT), noradrenaline (NA), (DA) transporters as multi-target directed ligands for treatment depression. All tested compounds demonstrated good affinity transporter (SERT). Among them, 11 4 emerged lead candidates because their promising pharmacological profile based in vitro studies. Compound displayed high 5-HT1A (Ki = 128.0 nM) D2 51.0 receptors, SERT 9.2 DAT 288.0 transporters, whereas compound exhibited most desirable binding to SERT/NET/DAT among series: Ki 47.0 nM/167.0 nM/43% inhibition at 1 µM. These results suggest that represent templates future development antidepressant drugs.

Язык: Английский

Процитировано

2

Interplay of G-proteins and Serotonin in the Neuroimmunoinflammatory Model of Chronic Stress and Depression: A Narrative Review DOI
Evgeni Gusev, Alexey Sarapultsev

Current Pharmaceutical Design, Год журнала: 2023, Номер 30(3), С. 180 - 214

Опубликована: Дек. 28, 2023

Introduction: This narrative review addresses the clinical challenges in stress-related disorders such as depression, focusing on interplay between neuron-specific and pro-inflammatory mechanisms at cellular, cerebral, systemic levels. Objective: We aim to elucidate molecular linking chronic psychological stress with low-grade neuroinflammation key brain regions, particularly roles of G proteins serotonin (5-HT) receptors. Methods: comprehensive literature employs systematic, narrative, scoping methodologies, combined approaches general pathology. It synthesizes current research shared signaling pathways involved responses neuroinflammation, including calcium-dependent mechanisms, mitogen-activated protein kinases, transcription factors like NF-κB p53. The also focuses role protein-coupled neurotransmitter receptors (GPCRs) immune responses, a detailed analysis how 13 14 types human 5-HT contribute depression neuroinflammation. Results: reveals complex interaction signals immunoinflammatory pathologies. highlights GPCRs canonical inflammatory mediators influencing both pathological physiological processes nervous tissue. Conclusion: proposed Neuroimmunoinflammatory Stress Model (NIIS Model) suggests that proinflammatory pathways, mediated by metabotropic ionotropic receptors, are crucial for maintaining neuronal homeostasis. Chronic mental can disrupt this balance, leading increased states contributing neuropsychiatric psychosomatic disorders, depression. model integrates traditional theories pathogenesis, offering understanding multifaceted nature condition.

Язык: Английский

Процитировано

5

The mechanistic effects of acupuncture in rodent neurodegenerative disease models: a literature review DOI Creative Commons
Boxuan Li, Shizhe Deng, Hailun Jiang

и другие.

Frontiers in Neuroscience, Год журнала: 2024, Номер 18

Опубликована: Март 4, 2024

Neurodegenerative diseases refer to a battery of medical conditions that affect the survival and function neurons in brain, which are mainly presented with progressive loss cognitive and/or motor function. Acupuncture showed benign effects improving neurological deficits, especially on movement impairment. Here, we reviewed therapeutic mechanisms acupuncture at neural circuit level cognition disorders, summarizing influence dopaminergic system, glutamatergic γ-amino butyric acid-ergic (GABAergic) serotonergic cholinergic glial cells synaptic levels. These findings can provide targets for clinical treatment perspectives further studies.

Язык: Английский

Процитировано

1

Magnesium sulfate ameliorates nicotine withdrawal–induced anxiety and depression: implications for regenerative psychiatry DOI
Murtaza Haidary, Maryam Nazari,

Sayed Mohammad Jawad Wasiq

и другие.

Regenerative medicine reports ., Год журнала: 2024, Номер 1(2), С. 222 - 231

Опубликована: Дек. 1, 2024

Nicotine withdrawal precipitates anxiety- and depression-like behaviors associated with disruptions in neurotransmitter systems, alterations glial neurotrophic factors, heightened oxidative stress. This study aimed to investigate the potential therapeutic effects of magnesium sulfate (MgSO₄) on nicotine withdrawal-induced anxiety depression rats as well its implications for regenerative psychiatry. These findings indicated that MgSO₄ administration effectively attenuated induced by rat model. The beneficial were accompanied modulation cortical serotonin metabolism, a reduction monoamine oxidase A activity, upregulation brain-derived factor, downregulation fibrillary acidic protein, amelioration stress behaviors. Therefore, can ameliorate detrimental at cellular behavioral levels has certain psychiatry, paving way application substance abuse-related diseases.

Язык: Английский

Процитировано

1